Clinical Trials Logo

Cancer clinical trials

View clinical trials related to Cancer.

Filter by:
  • Not yet recruiting  
  • Page 1 ·  Next »

NCT ID: NCT03952312 Not yet recruiting - Cancer Clinical Trials

Oncotool for Cancer Medications

Start date: May 2019
Phase: N/A
Study type: Interventional

The purpose of this study is to examine the efficacy of a psychosocial eHealth intervention on the proposed primary outcomes, TKI adherence and health related quality of life (HRQoL), in patients taking TKIs for cancer management. The intervention components include psychosocial management strategies, cancer medication knowledge and embedded physician reports. The intervention will be delivered via an online application over an 8-week period. Participants in the intervention will complete bi-weekly side effect questionnaires as part of their study involvement, which may trigger an alert to their prescribing physician if they reach a certain threshold. Participants in the control will not complete these questionnaires. Participants are randomized into either an intervention application (described above) or a control application (health information and general health promotion strategies). Aside from having access to the online application for the recommended 8 weeks, participation in this study includes three assessments: baseline (at the beginning of the research study), post-intervention (8 weeks after baseline) and a 6-month follow-up.

NCT ID: NCT03947606 Not yet recruiting - Cancer Clinical Trials

Pilot Optimization Trial of Decision Partnering Intervention for Advanced Cancer Family Caregivers

CASCADE
Start date: October 1, 2019
Phase: N/A
Study type: Interventional

Using a highly innovative methodology, the Multiphase Optimization Strategy (MOST), the purpose of this study is to pilot test, for the first time, an optimization trial approach to develop and refine the decision partnering skills of family caregivers of persons with newly-diagnosed advanced cancer. Using a 2x2x2 full factorial design, 40 family caregivers of persons with newly-diagnosed advanced cancer will be randomized to receive one or more nurse coach-delivered decision partnering training components, based on the Ottawa Decision Support Framework and Social Support Effectiveness Theory4: 1) psychoeducation on effective decision partnering principles (1 vs. 3 sessions); 2) decision partnering communication training (yes vs. no); and 3) Ottawa Decision Guide training (yes vs. no).

NCT ID: NCT03946397 Not yet recruiting - Cancer Clinical Trials

Impact of Multisensory Hand Massage on the Well-being of Cancer Patients

ONCOTACT
Start date: May 2019
Phase: N/A
Study type: Interventional

The investigators wish to study the impact of a multisensory hand massage on the immediate well-being of cancer patients.

NCT ID: NCT03943901 Not yet recruiting - Cancer Clinical Trials

Split-Dose R-CHOP for Older Adults With DLBCL

Start date: May 20, 2019
Phase: Phase 2
Study type: Interventional

This study is investigating a new administration schedule of Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, Prednisone (R-CHOP) chemotherapy for participants with Diffuse Large B-Cell Lymphoma (DLBCL), focusing on an underserved elderly population (aged 75 and up; certain participants 70-74 may be eligible) that is often excluded from clinical trials. Participants can expect to be on study for 2.5 years (treatment for 6 months and 2 years of post treatment follow-up).

NCT ID: NCT03943004 Not yet recruiting - Cancer Clinical Trials

Trial of DFP-14927 in Advanced Solid Tumors

Start date: July 1, 2019
Phase: Phase 1
Study type: Interventional

This is a Phase I, open-label, single-arm, dose escalation study of DFP-14927 intravenous infusion administered to patients with refractory or relapsed solid tumors.

NCT ID: NCT03941964 Not yet recruiting - Cancer Clinical Trials

A Study of the Effectiveness of Venetoclax in Combination With Azacitidine or Decitabine in an Outpatient Setting in Patients With Acute Myeloid Leukemia (AML) Ineligible for Intensive Chemotherapy

Start date: June 12, 2019
Phase: Phase 3
Study type: Interventional

A study evaluating the effectiveness and safety of venetoclax, in combination with azacitidine or decitabine, in an outpatient setting for treatment-naïve participants with AML who are ineligible for intensive chemotherapy.

NCT ID: NCT03940768 Not yet recruiting - Cancer Clinical Trials

The Use of Lactobacillus Plantarum 299v in Treatment of Cancer Patients Who Received Home Enteral Nutrition

Start date: May 10, 2019
Phase: N/A
Study type: Interventional

The aim of the study is to assess the impact of Lactobacillus plantarum 299v on nutritional status, tolerance of enteral diet and the quality of life. Administration of this probiotic may potentially improve nutritional status and tolerance of enteral diet. It also may provide positive effect on quality of life.

NCT ID: NCT03940053 Not yet recruiting - Cancer Clinical Trials

Prevention of Cancer Development and Progression

Start date: May 10, 2019
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the efficacy and safety of arginine in preventing cancer development

NCT ID: NCT03926143 Not yet recruiting - Cancer Clinical Trials

A Clinical Study of Anetumab Ravtansine in Adults With Solid Tumors Who Have Been Treated in Previous Bayer-sponsored Anetumab Ravtansine Studies

Start date: April 30, 2019
Phase: Phase 2
Study type: Interventional

The purpose of this study is to enable patients with solid tumors, who received anetumab ravtansine in a Bayer-sponsored clinical trial, to continue treatment after their respective study has been closed. The patients will be observed to collect information on how safe and efficient the drug is.

NCT ID: NCT03923296 Not yet recruiting - Cancer Clinical Trials

PERTH 2: Co-design of a Home-based Monitoring Service for Cancer Patients to Optimize Delivery of Systemic Therapy.

Start date: May 2019
Phase:
Study type: Observational

Iterative co-design study where patients receiving systemic cancer therapy, carers and healthcare professionals involved in delivering cancer therapy, work with Entia to design a home based blood monitoring service. The iterative process means that at each stage of the development process, Entia will be building on what is learnt in the previous stage.